These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 662975)

  • 21. Studies of MAO concentration and activity in schizophrenic patients.
    Abell CW; Fritz RB; Landowski J; Bessman JD; Castellani S; Boeringa JA; Rose RM
    Prog Clin Biol Res; 1982; 79():209-21. PubMed ID: 7088965
    [No Abstract]   [Full Text] [Related]  

  • 22. Platelet monoamine oxidase and the growth hormone response to apomorphine in schizophrenia.
    Malas KL; van Kammen DP; deFraites EA; Brown GM; Gold PW
    Biol Psychiatry; 1983 Feb; 18(2):255-9. PubMed ID: 6830934
    [No Abstract]   [Full Text] [Related]  

  • 23. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet monoamine oxidase in chronic schizophrenic patients.
    Berger PA; Ginsburg RA; Barchas JD; Murphy DL; Wyatt RJ
    Am J Psychiatry; 1978 Jan; 135(1):95-9. PubMed ID: 618534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The preliminary study of monoamine oxidase activity in platelets in patients with schizophrenia and affective disorder].
    Lin Y
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):325-7, 382. PubMed ID: 1304991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet monoamine oxidase activity in chronic schizophrenia.
    Trivedi JK; Tandon SK; Viswanathan PN; Gupta AK; Sethi BB
    Indian J Med Res; 1987 Jul; 86():79-83. PubMed ID: 3692563
    [No Abstract]   [Full Text] [Related]  

  • 27. Human platelet monoamine oxidase activity and in vivo manipulation of plasma glucose concentration.
    Jackman HL; Meltzer HY
    Commun Psychopharmacol; 1980; 4(5):335-8. PubMed ID: 7333090
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of oral glucose on platelet monoamine oxidase.
    Karson CN; Bridge TP; Phelps BH; Wise CD; Potkin SG; Apostoles PS; Wyatt RJ
    Biol Psychiatry; 1982 Sep; 17(9):1011-5. PubMed ID: 7138991
    [No Abstract]   [Full Text] [Related]  

  • 29. Platelet monoamine oxidase activity in schizophrenia.
    White HL; McLeod MN; Davidson JR
    Am J Psychiatry; 1976 Oct; 133(10):1191-3. PubMed ID: 970490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low platelet MAO activity in psychiatric patients and plasma factors: no evidence for inhibitory influences on MAO in the circulating platelet population.
    Demisch L; Gebhart P; Kaczmarczyk P; von der Mühlen H; Bochnik HJ
    Biol Psychiatry; 1981 Jan; 16(1):21-33. PubMed ID: 7225472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolactin levels in schizophrenia: relation to platelet monoamine oxidase, plasma amine oxidase, plasma dopamine-beta-hydroxylase, and erythrocyte catechol-O-methyltransferase activity.
    Baron M; Levitt M; Asnis L; Fein M
    Biol Psychiatry; 1983 May; 18(5):579-82. PubMed ID: 6860731
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of neuroleptics on platelet monoamine oxidase activity.
    Ho BT; Smith RC; Kralik P; Allen R; Schoolar J; Khan M; DeJohn C
    Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet monoamine oxidase in chronic schizophrenia.
    Berrettini WH; Vogel WH; Clouse R
    Am J Psychiatry; 1977 Jul; 134(7):805-7. PubMed ID: 869060
    [No Abstract]   [Full Text] [Related]  

  • 34. Reduced monoamine oxidase activity in platelets: a possible genetic marker for vulnerability to schizophrenia.
    Wyatt RJ; Murphy DL; Belmaker R; Cohen S; Donnelly CH; Pollin W
    Science; 1973 Mar; 179(4076):916-8. PubMed ID: 4687789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetic constants of platelet monoamine oxidase in schizophrenia.
    Jackman HL; Meltzer HY
    Am J Psychiatry; 1983 Aug; 140(8):1044-7. PubMed ID: 6869590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet monoamine oxidase: studies on the rate of heat inactivation in normal and in paranoid and nonparanoid chronic schizophrenic groups.
    Wise CD; Bridge TP; Potkin SG; Wyatt RJ
    Psychiatry Res; 1979 Oct; 1(2):187-90. PubMed ID: 298348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet monoamine oxidase activity in acute schizophrenia.
    Carpenter WT; Murphy DL; Wyatt RJ
    Am J Psychiatry; 1975 Apr; 132(4):438-41. PubMed ID: 1119597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Some kinetic parameters of platelet monoamine oxidase in chronic schizophrenia.
    Kobes RD; Potkin SG; Wise CD; Bridge TP; Neckers LM; Wyatt RJ
    Psychiatry Res; 1979 Oct; 1(2):179-85. PubMed ID: 298347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet MAO activity and schizophrenic prognosis.
    Gruen R; Baron M; Levitt M; Asnis L
    Am J Psychiatry; 1982 Feb; 139(2):240-1. PubMed ID: 7055302
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of neuroleptic drugs on platelet monoamine oxidase in psychiatric patients.
    Meltzer HY; Duncavage MB; Jackman H; Arora RC; Tricou BJ; Young M
    Am J Psychiatry; 1982 Oct; 139(10):1242-8. PubMed ID: 6127035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.